![]() |
|
|
Vol. 291, Issue 3, 1242-1249, December 1999
Department of Veterinary and Comparative Anatomy, Pharmacology and
Physiology, College of Veterinary Medicine, Washington State
University, Pullman, Washington
125I-Angiotensin (Ang) IV and 125I-divalinal
Ang IV [AT receptor subtype 4 (AT4)] receptor agonist and
putative antagonist, respectively] were used to characterize the
AT4 receptor in Mardin-Darby bovine kidney epithelial cells
(MDBK cell line). Both 125I-Ang IV and
125I-divalinal Ang IV bound to a single high-affinity site
(KD = 1.37 and 1.01 nM, respectively)
and to a comparable density of binding sites
(Bmax = 1335 and 1407 fmol/mg protein,
respectively). Competition of either radiolabeled ligand with several
Ang related peptides demonstrated similar displacement affinities in
the following affinity order: Ang IV = divalinal Ang IV > Ang III > Ang II > losartan = PD 123177. Guanosine-5'-O-(3-thio)triphosphate or sulfhydryl reducing agents did not affect the binding of either radiolabeled ligand. Brief exposure of MDBK cells to Ang IV or divalinal Ang IV (0.1 nM to 1 µM) caused a concentration-dependent rise in intracellular calcium concentration levels with a reduced calcium response observed with Ang IV at micromolar concentrations. These results indicate that
Ang IV and divalinal Ang IV bind with high affinity to the same
receptor and that the MDBK AT4 receptor is not coupled to a
classic G protein, nor are sulfhydryl bonds important in regulation of
receptor affinity. The MDBK AT4 receptor appears to be
pharmacologically similar to that described in nonrenal tissues.
Functional studies suggest that AT4 receptor activation can
increase intracellular calcium concentration levels in MDBK cells and
that divalinal Ang IV possesses agonist activity with respect to this
particular intracellular signaling system.
This article has been cited by other articles:
![]() |
C. M. Ferrario Commentary on Tikellis et al: There Is More to Discover About Angiotensin-Converting Enzyme Hypertension, March 1, 2003; 41(3): 390 - 391. [Full Text] [PDF] |
||||
![]() |
S. Nakamura, D. B. Averill, M. C. Chappell, D. I. Diz, K. B. Brosnihan, and C. M. Ferrario Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R164 - R173. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden Cellular targets for angiotensin II fragments: pharmacological and molecular evidence Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 195 - 204. [Abstract] [PDF] |
||||
![]() |
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF] |
||||
![]() |
R. K. Handa, S. E. Handa, and M. K. S. Elgemark Autoradiographic analysis and regulation of angiotensin receptor subtypes AT4, AT1, and AT(1---7) in the kidney Am J Physiol Renal Physiol, November 1, 2001; 281(5): F936 - F947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. HANDA Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449. [Abstract] [Full Text] |
||||
![]() |
S. Ito and A. F. Sved Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2961 - H2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, J. M. Patel, and E. R. Block Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L849 - L856. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. HANDA Metabolism Alters the Selectivity of Angiotensin-(1-7) Receptor Ligands for Angiotensin Receptors J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1377 - 1386. [Abstract] [Full Text] |
||||